SCHEMBL14619340

SCHEMBL14619340

COc1ccc(-c2cnnn2-c2cc(O)cc(OC)c2OC)cc1OC

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.57
SMN1; SMN2 Q16637 4/20 0.57
LMNA P02545 2/20 0.47
MAPT P10636 4/20 0.45
HPGD P15428 4/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
TP53 P04637 1/20 0.45
CYP3A4 P08684 2/20 0.45
NPSR1 Q6W5P4 2/20 0.45
MAPK1 P28482 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
TSHR P16473 1/20 0.45
CYP2C19 P33261 1/20 0.45
FYN P06241 2/20 0.40
KDM4E B2RXH2 2/20 0.39
RECQL P46063 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14619348 0.92 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2
SCHEMBL14619400 0.88 PTGS1 (0.46) ALDH1A1SMN1; SMN2LMNAMAPTHPGD
SCHEMBL14619396 0.88 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2MAPTCYP3A4
SCHEMBL410788 0.86 ALDH1A1 (0.58) ALDH1A1SMN1; SMN2LMNAMAPTHPGD
SCHEMBL14619344 0.86 CYP3A4 (0.41) ALDH1A1SMN1; SMN2LMNAMAPTCYP3A4
SCHEMBL14619341 0.85 PTGS1 (0.44) ALDH1A1SMN1; SMN2MAPTCYP3A4
SCHEMBL14619347 0.82 KCNMA1 (0.53) ALDH1A1LMNAMEN1KMT2A
SCHEMBL409456 0.81 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2LMNA
SCHEMBL14619397 0.81 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2LMNAMAPTHPGD
SCHEMBL413874 0.80 ALDH1A1 (0.67) ALDH1A1SMN1; SMN2LMNAMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007014198-A1 1, 2, 3 -TRIAZOLES INHIBITORS OF TUBULIN POLYMERIZATION FOR THE TREATMENT OF POLIFERATIVE DISORDERS SYNTA PHARMACEUTICALS CORP. (US) 2007-02-01 WO disclosed